Cancer Pain Market - Forecast(2024 - 2030)

Report Code: HCR 14904 Report Format: PDF + Excel
1. Cancer Pain Market - Overview
        1.1 Definitions and Scope
2. Cancer Pain Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Cancer Pain Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Cancer Pain Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Cancer Pain Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Cancer Pain Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Cancer Pain Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Cancer Pain Market - By Product Type(Market Size -$Million / $Billion)
        8.1 Market Size and Market Share Analysis
        8.2 Application Revenue and Trend Research
        8.3 Product Segment Analysis
9. Cancer Pain Market - By Type(Market Size -$Million / $Billion)
        9.1 CANCER PAIN MARKET, BY DRUG TYPE
            9.1.1 Opioids
                 9.1.1.1 Morphine
                 9.1.1.2 Fentanyl
            9.1.2 Non-opioids
                 9.1.2.1 Acetaminophen
                 9.1.2.2 Non-Steroidal Anti-Inflammatory Drugs
            9.1.3 Nerve blockers
        9.2 CANCER PAIN MARKET, BY DISEASE INDICATION
            9.2.1 Lung cancer
            9.2.2 Colorectal cancer
            9.2.3 Breast cancer
            9.2.4 Prostate cancer
            9.2.5 Blood cancer
10. Cancer Pain - By Application Type(Market Size -$Million / $Billion)
        10.1 Segment type Size and Market Share Analysis
        10.2 Application Revenue and Trends by type of Application
        10.3 Application Segment Analysis by Type
11. Cancer Pain- By Geography (Market Size -$Million / $Billion)
        11.1 Cancer Pain Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 Cancer Pain- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 Cancer Pain- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 Cancer Pain - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 Cancer Pain - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. Cancer Pain Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Cancer Pain Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Cancer Pain Market - Key Company List by Country Premium
15. Cancer Pain Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 AOXING PHARMACEUTICAL COMPANY, INC.
        15.3 BIODELIVERY SCIENCES INTERNATIONAL, INC.
        15.4 DAIICHI SANKYO CO., LTD.
        15.5 GRNENTHAL PHARMA GmbH CO. KG
        15.6 HISAMITSU PHARMACEUTICAL CO., INC.
        15.7 INSYS THERAPEUTICS, INC.
        15.8 MUNDIPHARMA INTERNATIONAL LIMITED
        15.9 OREXO AB
        15.10 PFIZER INC.
        15.11 TEVA PHARMACEUTICAL INDUSTRIES LIMITED
        15.12 Company 12
        15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Cancer Pain Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Cancer Pain Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global CANCER PAIN MARKET, BY DRUG TYPE Market 2023-2030 ($M)
1.1 Opioids Market 2023-2030 ($M) - Global Industry Research
1.1.1 Morphine Market 2023-2030 ($M)
1.1.2 Fentanyl Market 2023-2030 ($M)
1.2 Non-opioids Market 2023-2030 ($M) - Global Industry Research
1.2.1 Acetaminophen Market 2023-2030 ($M)
1.2.2 Non-Steroidal Anti-Inflammatory Drugs Market 2023-2030 ($M)
1.3 Nerve blockers Market 2023-2030 ($M) - Global Industry Research
2.Global CANCER PAIN MARKET, BY DISEASE INDICATION Market 2023-2030 ($M)
2.1 Lung cancer Market 2023-2030 ($M) - Global Industry Research
2.2 Colorectal cancer Market 2023-2030 ($M) - Global Industry Research
2.3 Breast cancer Market 2023-2030 ($M) - Global Industry Research
2.4 Prostate cancer Market 2023-2030 ($M) - Global Industry Research
2.5 Blood cancer Market 2023-2030 ($M) - Global Industry Research
3.Global CANCER PAIN MARKET, BY DRUG TYPE Market 2023-2030 (Volume/Units)
3.1 Opioids Market 2023-2030 (Volume/Units) - Global Industry Research
3.1.1 Morphine Market 2023-2030 (Volume/Units)
3.1.2 Fentanyl Market 2023-2030 (Volume/Units)
3.2 Non-opioids Market 2023-2030 (Volume/Units) - Global Industry Research
3.2.1 Acetaminophen Market 2023-2030 (Volume/Units)
3.2.2 Non-Steroidal Anti-Inflammatory Drugs Market 2023-2030 (Volume/Units)
3.3 Nerve blockers Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global CANCER PAIN MARKET, BY DISEASE INDICATION Market 2023-2030 (Volume/Units)
4.1 Lung cancer Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Colorectal cancer Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Breast cancer Market 2023-2030 (Volume/Units) - Global Industry Research
4.4 Prostate cancer Market 2023-2030 (Volume/Units) - Global Industry Research
4.5 Blood cancer Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America CANCER PAIN MARKET, BY DRUG TYPE Market 2023-2030 ($M)
5.1 Opioids Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Morphine Market 2023-2030 ($M)
5.1.2 Fentanyl Market 2023-2030 ($M)
5.2 Non-opioids Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Acetaminophen Market 2023-2030 ($M)
5.2.2 Non-Steroidal Anti-Inflammatory Drugs Market 2023-2030 ($M)
5.3 Nerve blockers Market 2023-2030 ($M) - Regional Industry Research
6.North America CANCER PAIN MARKET, BY DISEASE INDICATION Market 2023-2030 ($M)
6.1 Lung cancer Market 2023-2030 ($M) - Regional Industry Research
6.2 Colorectal cancer Market 2023-2030 ($M) - Regional Industry Research
6.3 Breast cancer Market 2023-2030 ($M) - Regional Industry Research
6.4 Prostate cancer Market 2023-2030 ($M) - Regional Industry Research
6.5 Blood cancer Market 2023-2030 ($M) - Regional Industry Research
7.South America CANCER PAIN MARKET, BY DRUG TYPE Market 2023-2030 ($M)
7.1 Opioids Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Morphine Market 2023-2030 ($M)
7.1.2 Fentanyl Market 2023-2030 ($M)
7.2 Non-opioids Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Acetaminophen Market 2023-2030 ($M)
7.2.2 Non-Steroidal Anti-Inflammatory Drugs Market 2023-2030 ($M)
7.3 Nerve blockers Market 2023-2030 ($M) - Regional Industry Research
8.South America CANCER PAIN MARKET, BY DISEASE INDICATION Market 2023-2030 ($M)
8.1 Lung cancer Market 2023-2030 ($M) - Regional Industry Research
8.2 Colorectal cancer Market 2023-2030 ($M) - Regional Industry Research
8.3 Breast cancer Market 2023-2030 ($M) - Regional Industry Research
8.4 Prostate cancer Market 2023-2030 ($M) - Regional Industry Research
8.5 Blood cancer Market 2023-2030 ($M) - Regional Industry Research
9.Europe CANCER PAIN MARKET, BY DRUG TYPE Market 2023-2030 ($M)
9.1 Opioids Market 2023-2030 ($M) - Regional Industry Research
9.1.1 Morphine Market 2023-2030 ($M)
9.1.2 Fentanyl Market 2023-2030 ($M)
9.2 Non-opioids Market 2023-2030 ($M) - Regional Industry Research
9.2.1 Acetaminophen Market 2023-2030 ($M)
9.2.2 Non-Steroidal Anti-Inflammatory Drugs Market 2023-2030 ($M)
9.3 Nerve blockers Market 2023-2030 ($M) - Regional Industry Research
10.Europe CANCER PAIN MARKET, BY DISEASE INDICATION Market 2023-2030 ($M)
10.1 Lung cancer Market 2023-2030 ($M) - Regional Industry Research
10.2 Colorectal cancer Market 2023-2030 ($M) - Regional Industry Research
10.3 Breast cancer Market 2023-2030 ($M) - Regional Industry Research
10.4 Prostate cancer Market 2023-2030 ($M) - Regional Industry Research
10.5 Blood cancer Market 2023-2030 ($M) - Regional Industry Research
11.APAC CANCER PAIN MARKET, BY DRUG TYPE Market 2023-2030 ($M)
11.1 Opioids Market 2023-2030 ($M) - Regional Industry Research
11.1.1 Morphine Market 2023-2030 ($M)
11.1.2 Fentanyl Market 2023-2030 ($M)
11.2 Non-opioids Market 2023-2030 ($M) - Regional Industry Research
11.2.1 Acetaminophen Market 2023-2030 ($M)
11.2.2 Non-Steroidal Anti-Inflammatory Drugs Market 2023-2030 ($M)
11.3 Nerve blockers Market 2023-2030 ($M) - Regional Industry Research
12.APAC CANCER PAIN MARKET, BY DISEASE INDICATION Market 2023-2030 ($M)
12.1 Lung cancer Market 2023-2030 ($M) - Regional Industry Research
12.2 Colorectal cancer Market 2023-2030 ($M) - Regional Industry Research
12.3 Breast cancer Market 2023-2030 ($M) - Regional Industry Research
12.4 Prostate cancer Market 2023-2030 ($M) - Regional Industry Research
12.5 Blood cancer Market 2023-2030 ($M) - Regional Industry Research
13.MENA CANCER PAIN MARKET, BY DRUG TYPE Market 2023-2030 ($M)
13.1 Opioids Market 2023-2030 ($M) - Regional Industry Research
13.1.1 Morphine Market 2023-2030 ($M)
13.1.2 Fentanyl Market 2023-2030 ($M)
13.2 Non-opioids Market 2023-2030 ($M) - Regional Industry Research
13.2.1 Acetaminophen Market 2023-2030 ($M)
13.2.2 Non-Steroidal Anti-Inflammatory Drugs Market 2023-2030 ($M)
13.3 Nerve blockers Market 2023-2030 ($M) - Regional Industry Research
14.MENA CANCER PAIN MARKET, BY DISEASE INDICATION Market 2023-2030 ($M)
14.1 Lung cancer Market 2023-2030 ($M) - Regional Industry Research
14.2 Colorectal cancer Market 2023-2030 ($M) - Regional Industry Research
14.3 Breast cancer Market 2023-2030 ($M) - Regional Industry Research
14.4 Prostate cancer Market 2023-2030 ($M) - Regional Industry Research
14.5 Blood cancer Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Cancer Pain Market Revenue, 2023-2030 ($M)
2.Canada Cancer Pain Market Revenue, 2023-2030 ($M)
3.Mexico Cancer Pain Market Revenue, 2023-2030 ($M)
4.Brazil Cancer Pain Market Revenue, 2023-2030 ($M)
5.Argentina Cancer Pain Market Revenue, 2023-2030 ($M)
6.Peru Cancer Pain Market Revenue, 2023-2030 ($M)
7.Colombia Cancer Pain Market Revenue, 2023-2030 ($M)
8.Chile Cancer Pain Market Revenue, 2023-2030 ($M)
9.Rest of South America Cancer Pain Market Revenue, 2023-2030 ($M)
10.UK Cancer Pain Market Revenue, 2023-2030 ($M)
11.Germany Cancer Pain Market Revenue, 2023-2030 ($M)
12.France Cancer Pain Market Revenue, 2023-2030 ($M)
13.Italy Cancer Pain Market Revenue, 2023-2030 ($M)
14.Spain Cancer Pain Market Revenue, 2023-2030 ($M)
15.Rest of Europe Cancer Pain Market Revenue, 2023-2030 ($M)
16.China Cancer Pain Market Revenue, 2023-2030 ($M)
17.India Cancer Pain Market Revenue, 2023-2030 ($M)
18.Japan Cancer Pain Market Revenue, 2023-2030 ($M)
19.South Korea Cancer Pain Market Revenue, 2023-2030 ($M)
20.South Africa Cancer Pain Market Revenue, 2023-2030 ($M)
21.North America Cancer Pain By Application
22.South America Cancer Pain By Application
23.Europe Cancer Pain By Application
24.APAC Cancer Pain By Application
25.MENA Cancer Pain By Application
26.AOXING PHARMACEUTICAL COMPANY, INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.BIODELIVERY SCIENCES INTERNATIONAL, INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.DAIICHI SANKYO CO., LTD., Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.GRNENTHAL PHARMA GmbH CO. KG, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.HISAMITSU PHARMACEUTICAL CO., INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.INSYS THERAPEUTICS, INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.MUNDIPHARMA INTERNATIONAL LIMITED, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.OREXO AB, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.PFIZER INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.TEVA PHARMACEUTICAL INDUSTRIES LIMITED, Sales /Revenue, 2015-2018 ($Mn/$Bn)